References
Available at http://www.ugc.edu.hk/chs/rgc/index.html
Available at http://www.itc.gov.hk/ch/about/index.htm
Available at http://rfs2.fhb.gov.hk/chs/funds/funds_hmrf/funds_ hmrf_abt/funds_hmrf_abt.html
Available at http://www.ugc.edu.hk/eng/ugc/activity/research/rae. html
Wang C, Liu B, Xu X, Zhuang B, Li H, Yin J, et al. Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine. Oncotarget 2016;7:8360–8372.
Chu ES, Sze SC, Cheung HP, Wong KL, Liu Q, Ng TB, et al. Differential effects of anti-metastatic mechanism of Tian-Xian Liquid (TXL) and its bioactive fractions on human colorectal cancer models. J Ethnopharmacol 2011;137:403–413.
Zhong LL, Cheng CW, Chan Y, Chan KH, Lam TW, Chen XR, et al. Chinese herbal medicine (Ma Zi Ren Wan) for functional constipation: study protocol for a prospective, double-blinded, double-dummy, randomized controlled trial. Trials 2013;14:366.
China Academy of Chinese Medical Sciences. Evidence-based guideline of clinical practice in Chinese medicine. Beijing: China Traditional Medicine Press; 2011.
Yuwen Y, Shi NN, Han XJ, Gao Y, Xu JL, Liu DS, et al. Appraisal of clinical practice guidelines for ischemic stroke management in Chinese medicine with appraisal of guidelines for research and evaluation instrument: a systematic review. Chin J Integr Med 2015;21:707–715.
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting, and evaluation in health care. Prev Med 2010;51:421–424.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lu, Ap., Cheng, Sp. & Liu, B. Development of Chinese medicine research in Hong Kong, China in last decade. Chin. J. Integr. Med. 23, 483–485 (2017). https://doi.org/10.1007/s11655-017-2816-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-017-2816-y